Literature DB >> 26404185

Curcumin and its analogues: a potential natural compound against HIV infection and AIDS.

Sahdeo Prasad1, Amit K Tyagi.   

Abstract

No safe and effective cure currently exists for human immunodeficiency virus (HIV). However, antiretroviral therapy can prolong the lives of HIV patients and lowers the secondary infections. Natural compounds, which are considered to be pleiotropic molecules, could be useful against HIV. Curcumin, a yellow pigment present in the spice turmeric (Curcuma longa), can be used for the treatment of several diseases including HIV-AIDS because of its antioxidant, anti-inflammatory, anticancer, antiviral, and antibacterial nature. In this review we have summarized that how curcumin and its analogues inhibit the infection and replication of viral genes and prevent multiplicity of HIV. They are inhibitors of HIV protease and integrase. Curcumin also inhibits Tat transactivation of the HIV1-LTR genome, inflammatory molecules (interleukins, TNF-α, NF-κB, COX-2) and HIV associated various kinases including tyrosine kinase, PAK1, MAPK, PKC, cdk and others. In addition, curcumin enhances the effect of conventional therapeutic drugs and minimizes their side effects.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26404185     DOI: 10.1039/c5fo00485c

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  24 in total

Review 1.  Endophytic Microbial Diversity: A New Hope for the Production of Novel Anti-tumor and Anti-HIV Agents as Future Therapeutics.

Authors:  Aditya Banyal; Vikram Thakur; Rahul Thakur; Pradeep Kumar
Journal:  Curr Microbiol       Date:  2021-03-16       Impact factor: 2.188

Review 2.  Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies.

Authors:  Mohitosh Biswas; Nares Sawajan; Thanyada Rungrotmongkol; Kamonpan Sanachai; Maliheh Ershadian; Chonlaphat Sukasem
Journal:  Front Pharmacol       Date:  2022-02-18       Impact factor: 5.810

3.  EF24 induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in gastric cancer cells.

Authors:  Peng Zou; Yiqun Xia; Weiqian Chen; Xi Chen; Shilong Ying; Zhiguo Feng; Tongke Chen; Qingqing Ye; Zhe Wang; Chenyu Qiu; Shulin Yang; Guang Liang
Journal:  Oncotarget       Date:  2016-04-05

Review 4.  ErbB Proteins as Molecular Target of Dietary Phytochemicals in Malignant Diseases.

Authors:  Alexandru Filippi; Oana-Alina Ciolac; Constanța Ganea; Maria-Magdalena Mocanu
Journal:  J Oncol       Date:  2017-02-13       Impact factor: 4.375

5.  Optical Spectroscopic and Morphological Characterizations of Curcuminized Silk Biomaterials: A Perspective from Drug Stabilization.

Authors:  Sudipta Panja; Sibaram Behera; Subhas C Kundu; Mintu Halder
Journal:  ACS Omega       Date:  2017-10-16

Review 6.  Role of Iron Chelation and Protease Inhibition of Natural Products on COVID-19 Infection.

Authors:  Giuseppe Carota; Simone Ronsisvalle; Federica Panarello; Daniele Tibullo; Anna Nicolosi; Giovanni Li Volti
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

7.  Interaction of Natural Compounds in Licorice and Turmeric with HIV-NCp7 Zinc Finger Domain: Potential Relevance to the Mechanism of Antiviral Activity.

Authors:  Runjing Wang; Yinyu Wei; Meiqin Wang; Pan Yan; Hongliang Jiang; Zhifeng Du
Journal:  Molecules       Date:  2021-06-10       Impact factor: 4.411

8.  Anti-HIV Activity of Cucurbitacin-D against Cigarette Smoke Condensate-Induced HIV Replication in the U1 Macrophages.

Authors:  Sunitha Kodidela; Namita Sinha; Asit Kumar; Santosh Kumar
Journal:  Viruses       Date:  2021-05-27       Impact factor: 5.048

Review 9.  Potential pharmacological approaches for the treatment of HIV-1 associated neurocognitive disorders.

Authors:  Amila Omeragic; Olanre Kayode; Md Tozammel Hoque; Reina Bendayan
Journal:  Fluids Barriers CNS       Date:  2020-07-10

10.  Curcumin as a potential treatment for COVID-19.

Authors:  Francisco Airton Castro Rocha; Marcos Renato de Assis
Journal:  Phytother Res       Date:  2020-06-09       Impact factor: 6.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.